The Impact of Polymorphic Variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the Risk and Prognosis of Portuguese Patients with Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

The Impact of Polymorphic Variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the Risk and Prognosis of Portuguese Patients with Non-Small Cell Lung Cancer

Published:2013-09-06 Issue:9 Volume:8 Page:e72373
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

de Mello Ramon Andrade,Ferreira Mónica,Soares-Pires Filipa,Costa Sandra,Cunha João,Oliveira Pedro,Hespanhol Venceslau,Reis Rui Manuel

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. Global cancer statistics;A Jemal;CA Cancer J Clin,2011

2. Cancer statistics, 2012;R Siegel;CA Cancer J Clin,2012

3. Personalizing medicine - strategies for implementing the evaluation of ALK rearrangement in non-small-cell lung cancer in Portugal;A Araújo;Rev Port Pneumol,2012

4. Cancer treatment and survivorship statistics, 2012;R Siegel;CA Cancer J Clin,2012

5. Insights into Angiogenesis in Non-Small Cell Lung Cancer: Molecular Mechanisms, Polymorphic Genes, and Targeted Therapies;RA de Mello;Recent Pat Anticancer Drug Discov,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The updated relationship between the cleft‑lip and palate transmembrane protein‑1‑like rs401681 and lung cancer risk: A systematic review and meta‑analysis;Molecular and Clinical Oncology;2024-07-31

2. The relationship between VEGF-460(T>C) polymorphism and cancer risk: A systematic review and meta-analysis based on 46 reports;Medicine;2023-06-30

3. Six minor allele variants in the TERT-CLPTM1L region are associated with lung cancer risk: a meta-analysis based on different ethnicities and different lung cancer subtypes;2023-06-30

4. Vascular endothelial growth factor A (VEGFA) promoter rs2010963 polymorphism and cancer risk: An updated meta-analysis and trial sequential analysis;Meta Gene;2022-02

5. Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study;Frontiers in Oncology;2021-07-26